316 related articles for article (PubMed ID: 36860323)
1. The emerging role of microtubules in invasion plasticity.
Legátová A; Pelantová M; Rösel D; Brábek J; Škarková A
Front Oncol; 2023; 13():1118171. PubMed ID: 36860323
[TBL] [Abstract][Full Text] [Related]
2. Actin cytoskeleton in mesenchymal-to-amoeboid transition of cancer cells.
Alexandrova AY; Chikina AS; Svitkina TM
Int Rev Cell Mol Biol; 2020; 356():197-256. PubMed ID: 33066874
[TBL] [Abstract][Full Text] [Related]
3. Plasticity of cancer cell invasion: Patterns and mechanisms.
Wu JS; Jiang J; Chen BJ; Wang K; Tang YL; Liang XH
Transl Oncol; 2021 Jan; 14(1):100899. PubMed ID: 33080522
[TBL] [Abstract][Full Text] [Related]
4. Increased Level of Long Non-Coding RNA MALAT1 is a Common Feature of Amoeboid Invasion.
Merta L; Gandalovičová A; Čermák V; Dibus M; Gutschner T; Diederichs S; Rösel D; Brábek J
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32369931
[TBL] [Abstract][Full Text] [Related]
5. Amoeboid-mesenchymal migration plasticity promotes invasion only in complex heterogeneous microenvironments.
Talkenberger K; Cavalcanti-Adam EA; Voss-Böhme A; Deutsch A
Sci Rep; 2017 Aug; 7(1):9237. PubMed ID: 28835679
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells.
Lehmann S; Te Boekhorst V; Odenthal J; Bianchi R; van Helvert S; Ikenberg K; Ilina O; Stoma S; Xandry J; Jiang L; Grenman R; Rudin M; Friedl P
Curr Biol; 2017 Feb; 27(3):392-400. PubMed ID: 28089517
[TBL] [Abstract][Full Text] [Related]
7. Transition from mesenchymal to bleb-based motility is predominantly exhibited by CD133-positive subpopulation of fibrosarcoma cells.
Chikina AS; Rubtsova SN; Lomakina ME; Potashnikova DM; Vorobjev IA; Alexandrova AY
Biol Cell; 2019 Oct; 111(10):245-261. PubMed ID: 31403697
[TBL] [Abstract][Full Text] [Related]
8. The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.
Margheri F; Luciani C; Taddei ML; Giannoni E; Laurenzana A; Biagioni A; Chillà A; Chiarugi P; Fibbi G; Del Rosso M
Oncotarget; 2014 Mar; 5(6):1538-53. PubMed ID: 24681666
[TBL] [Abstract][Full Text] [Related]
9. Cancer Cells Invade Confined Microchannels via a Self-Directed Mesenchymal-to-Amoeboid Transition.
Holle AW; Govindan Kutty Devi N; Clar K; Fan A; Saif T; Kemkemer R; Spatz JP
Nano Lett; 2019 Apr; 19(4):2280-2290. PubMed ID: 30775927
[TBL] [Abstract][Full Text] [Related]
10. How does plasticity of migration help tumor cells to avoid treatment: Cytoskeletal regulators and potential markers.
Alexandrova A; Lomakina M
Front Pharmacol; 2022; 13():962652. PubMed ID: 36278174
[TBL] [Abstract][Full Text] [Related]
11. Scared stiff: Stabilizing the actin cytoskeleton to stop invading cancer cells in their tracks.
O'Neill GM
Bioarchitecture; 2011 Jan; 1(1):29-31. PubMed ID: 21866259
[TBL] [Abstract][Full Text] [Related]
12. Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis.
Chillà A; Margheri F; Biagioni A; Del Rosso M; Fibbi G; Laurenzana A
J Exp Clin Cancer Res; 2018 Apr; 37(1):74. PubMed ID: 29615071
[TBL] [Abstract][Full Text] [Related]
13. Markers of Cancer Cell Invasion: Are They Good Enough?
Gerashchenko TS; Novikov NM; Krakhmal NV; Zolotaryova SY; Zavyalova MV; Cherdyntseva NV; Denisov EV; Perelmuter VM
J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31344926
[TBL] [Abstract][Full Text] [Related]
14. PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness.
Vaškovičová K; Szabadosová E; Čermák V; Gandalovičová A; Kasalová L; Rösel D; Brábek J
BMC Cancer; 2015 Apr; 15():326. PubMed ID: 25924946
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.
Elson-Schwab I; Lorentzen A; Marshall CJ
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957176
[TBL] [Abstract][Full Text] [Related]
16. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces.
Rösel D; Brábek J; Tolde O; Mierke CT; Zitterbart DP; Raupach C; Bicanová K; Kollmannsberger P; Panková D; Vesely P; Folk P; Fabry B
Mol Cancer Res; 2008 Sep; 6(9):1410-20. PubMed ID: 18819929
[TBL] [Abstract][Full Text] [Related]
18. Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion.
Jobe NP; Åsberg L; Andersson T
Mol Oncol; 2021 Jul; 15(7):1835-1848. PubMed ID: 33969605
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel.
Oyanagi J; Ogawa T; Sato H; Higashi S; Miyazaki K
PLoS One; 2012; 7(12):e53209. PubMed ID: 23300891
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
Belgiovine C; Frapolli R; Bonezzi K; Chiodi I; Favero F; Mello-Grand M; Dei Tos AP; Giulotto E; Taraboletti G; D'Incalci M; Mondello C
PLoS One; 2010 Nov; 5(11):e14154. PubMed ID: 21209796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]